新威國際(00058.HK):要約人持股僅48.81% 要約已失效
格隆匯6月2日丨新威國際(00058.HK)公佈,於2020年6月2日下午四時正,要約人已收到22份有關合共6522.4萬股要約股份的有效接納,佔於本聯合公告日期已發行股份約7.27%。
於本聯合公告日期,接納股份連同要約人及其一致行動人士已擁有的股份為合共4.38億股股份,佔公司全部已發行股本約48.81%。由於接納條件並無達成,該等要約並無成為無條件。
要約人宣佈,將不會延長或修訂該等要約,該等要約將於2020年6月2日下午四時正截止接納及失效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.